Actionnariat et activité des initiés pour Aligos Therapeutics, Inc. (ALGS): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $5.05 |
| Capitalisation | $31M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-25 | Preston Heather | A-Award | 5,860 | $32K |
| 2026-06-25 | Chavez Margarita | A-Award | 5,860 | $32K |
| 2026-06-25 | Martell Bridget A | A-Award | 5,860 | $32K |
| 2026-06-25 | Scopa James Paul | A-Award | 5,860 | $32K |
| 2026-06-25 | Nuechterlein Carole | A-Award | 5,860 | $32K |
| 2026-06-25 | Hirth Peter | A-Award | 5,860 | $32K |
| 2026-03-09 | Symons Julian A. | A-Award | 23,310 | $164K |
| 2026-03-09 | Aneja Nikhil | A-Award | 9,450 | $66K |
| 2026-03-09 | Calhoun Lesley Ann | A-Award | 37,485 | $264K |
| 2026-03-09 | BLATT LAWRENCE | A-Award | 105,840 | $744K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $24.0M | $69.6M | $220.4M | $186.8M | $81.3M | $135.7M | $37.0M | $18.3M |
| Placements à Court Terme | $66.8M | $48.1M | $23.1M | $3.9M | $44.5M | 0 | $19.9M | $59.5M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $92.4M | $120.2M | $250.0M | $204.4M | $133.5M | $141.1M | $62.1M | $82.9M |
| Immobilisations Corporelles | $15.2M | $16.1M | $14.9M | $15.0M | $12.5M | $9.8M | $7.3M | $5.0M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $107.7M | $146.5M | $265.3M | $235.4M | $146.7M | $151.5M | $70.1M | $88.5M |
| Dettes Fournisseurs | $3.0M | $3.8M | $3.3M | $3.0M | $4.7M | $2.5M | $2.6M | $4.0M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $7.5M | $13.8M | $30.3M | $39.0M | $33.1M | $23.9M | $21.7M | $21.2M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $121.5M | $211.4M | $45.3M | $50.6M | $42.8M | $59.4M | $99.1M | $35.0M |
| Réserves | -$13.9M | -$66.2M | -$174.7M | -$303.1M | -$399.1M | -$486.8M | -$618.0M | -$642.2M |
| Capitaux Propres | -$13.7M | -$64.9M | $220.0M | $184.7M | $103.9M | $92.1M | -$29.0M | $53.5M |
| Dette Totale | $13.9M | $14.3M | $13.0M | $14.5M | $12.6M | $11.1M | $8.4M | $5.2M |
| Dette Nette | -$77.0M | -$103.3M | -$230.5M | -$176.3M | -$113.3M | -$124.6M | -$48.6M | -$72.6M |
| Fonds de Roulement | $84.9M | $106.4M | $219.7M | $165.5M | $100.4M | $117.2M | $40.4M | $61.6M |
Santé financière
| Dette / Capitaux propres | 0.11 |
| Ratio de liquidité | 2.19 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -10.99 |
Rentabilité
| Rentabilité des capitaux propres | -160.72% |
| Rentabilité du capital investi | -191.73% |
| Rentabilité des actifs | -114.53% |
| Marge brute | 99.18% |
| Marge opérationnelle | -250.63% |
| Marge nette | -241.01% |
Entreprises liées: BRNS · CVM · FGEN · INMB · KZR · MRSN · OKUR
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ALGS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions